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Objective: Myocardial apoptosis is observed after various cardiac injuries and is also a
normal part of fetal cardiac development and early postnatal maturation. Cardioplegic
arrest and reperfusion result in ischemic injury and oxidative stress, known triggers of
apoptosis. Because the neonatal heart is in a proapoptotic state, we hypothesize that
apoptosis is triggered after cardioplegic arrest in neonatal myocardium.
Methods: We started neonatal lambs (6-8 days old, n  5) on cardiopulmonary
bypass and administered cold crystalloid cardioplegia at 20-minute intervals. Total
crossclamp time was 70 minutes, and bypass time was 90 minutes. After a six-hour
recovery period, the hearts were excised and examined by using TdT-mediated
dUTP nick-end labeling; radiolabeled DNA electrophoresis; fluorimetric caspase 3,
8, and 9 activity assay; mRNA microarray; and Western immunoblotting. Control
lambs were anesthetized but did not undergo operation (n  5) or were started on
cardiopulmonary bypass for 90 minutes but not arrested (n  5).
Results: Lambs subjected to cardioplegia had 5-fold more TdT-mediated dUTP
nick-end labeling–positive nuclei compared with that seen in unoperated control
animals (P  .007) and bypass-only control animals (P  .008). DNA laddering
was present in all postcardioplegia hearts but absent among control hearts. Bad and
Bcl-X mRNA transcription increased significantly. Caspase 3, 8, and 9 activities
were slightly greater than those seen in control animals, but the differences were not
significant. No change was detected in Bcl-2, Bax, or Bcl-xL proteins.
Conclusions: In a clinically relevant model of neonatal cardioplegic arrest, increased
apoptotic cell death is present 6 hours after reperfusion, and both proapoptotic and
antiapoptotic responses are triggered. The clinical implications of apoptosis after
cardioplegic arrest remain undetermined.
Apoptosis is a program for the orderly deletion of injured andobsolete cells. The instigating signal for apoptosis can come fromthe cell surface through Fas or tumor necrosis factor binding, fromthe mitochondrion in response to sublethal ischemia or oxidativestress, or through a variety of other stimuli.1-5 Apoptosis isdistinct from necrosis in that the cell is dismantled by a family of
specific proteases, the caspases, and endonucleases. Early in apoptosis, myocardial
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cells become dysfunctional because of mitochondrial
changes and derangement of structural and functional pro-
teins.6 They might remain in this dysfunctional state for a
variable period or proceed to cleavage of genomic DNA and
segmentation of the cell into apoptotic bodies, which are
endocytosed by neighboring cells.
Although myocardial apoptosis has been thought of as
the result of pathologic processes, it has also been shown to
be a normal component of fetal cardiac development and
early postnatal maturation.7,8 Within the neonatal period,
expression of proapoptotic signals is increased in the myo-
cardium,9 suggesting a greater susceptibility to apoptosis. It
has recently been suggested that apoptosis is initiated during
cardioplegic arrest in diseased adult hearts and might play a
role in postoperative myocardial stunning.10 We therefore
hypothesize that in a clinically relevant model of neonatal
cardiac surgery, a brief period of hypothermic cardioplegic
arrest will result in increased apoptotic cell death and acti-
vation of apoptotic signaling pathways.
Methods
Surgical Protocol
Six- to 8-day-old lambs (n  5) were anesthetized with intrave-
nous thiopental sodium (Pentothal), intubated orotracheally, and
maintained with inhalational general anesthesia for the duration of
the experiment. Through a median sternotomy, right atrial and
aortic cannulas were placed, and cardiopulmonary bypass was
initiated with passive cooling to 28°C to 30°C. The ductus arte-
riosis was ligated if patent. The aorta was then crossclamped, and
Abbott cardioplegic solution with 20 mEq/L potassium was deliv-
ered at 4°C into an aortic root needle with 50 to 70 mm Hg
perfusion pressure to a total initial dose of 20 mL/kg body weight.
Subsequent cold cardioplegia doses of 15 mL/kg were delivered at
20-minute intervals. Between cardioplegia doses, topical cooling
was applied, and the aortic root and pulmonary artery were vented.
After 70 minutes of arrest, the crossclamp was removed, and after
a 10- to 20-minute stabilization period, bypass was terminated, and
the perfusion cannulas were removed.
General anesthesia was maintained for 6 hours after reperfu-
sion, during which time arterial blood gases, electrolytes, and
hematocrit levels were maintained in a physiologic range, and
maternal blood or crystalloid solution was infused as necessary to
maintain arterial pressure. Inotropic agents were not administered.
After 6 hours, the heart was quickly excised and perfused through
the coronary arteries with 240 mL of ice-cold phosphate-buffered
saline solution. Full-thickness, 1-cm2 myocardial samples for his-
tologic study were taken from the center of the left ventricular free
wall, frozen in OCT (Sakui, Torrance, Calif) on Dry Ice, and then
stored at 80°C until sectioning or stored in 10% neutral (phos-
phate)–buffered formalin at room temperature. The remainder of
the left ventricular free wall was minced and snap-frozen in liquid
nitrogen. Nonoperated control lambs (n  5) were anesthetized in
a similar manner, and the hearts were immediately excised and
processed as above but without a 6-hour delay. Cardiopulmonary
bypass–only control lambs (n  5) were started on cardiopulmo-
nary bypass in the empty beating state without cardioplegic arrest.
After 90 minutes, they were weaned from bypass, decannulated,
and maintained for 6 hours before the harvest of myocardial tissue.
All procedures were performed within the regulations of the
Animal Welfare Act and the “National Institutes of Health Guide
for the Care and Use of Laboratory Animals” and were approved
by the University of Iowa Animal Care and Use Committee.
In Situ TdT-Mediated dUTP-Digoxigenin Nick End-
Labeling
In situ TdT-mediated dUTP-digoxigenin nick end-labeling
(TUNEL) was performed with a modification of the technique
described by Olivetti and colleagues,2 using the ApopTag In Situ
kit (Intergen, Norcross, Ga). In brief, 5-m cryostat sections were
fixed with freshly prepared 1% paraformaldehyde in phosphate-
buffered saline solution at room temperature for 10 minutes, pre-
incubated with equilibration buffer for 5 minutes, and subse-
quently incubated with deoxyribonucleotidyl transferase in the
presence of digoxigenin-conjugated dUTP for 1 hour at 37°C. The
reaction was terminated by incubating the samples in stopping
buffer and then with the fluorescein-labeled anti-digoxigenin an-
tibody (yellow-green). Cell nuclei were counterstained with 4’,6-
Diamidino-2-phenylindole (DAPI; Vector Laboratories, Burlin-
game, Calif). Ten random high-power fields representing
approximately 4000 cells were counted to enumerate TUNEL-
positive cells. Formalin-fixed and paraffin-embedded 5-m sec-
tions were stained with mouse monoclonal immunoglobulin M
(IgM) anti--sarcomeric actin antibody (Sigma, St Louis, Mo) and
Alexa Fluor 594–conjugated goat anti-mouse IgM (Molecular
Probes, Eugene, Ore) and then TUNEL stained as above to identify
cell type. Adjacent sections were stained with hematoxylin and
eosin and examined by means of light microscopy for evidence of
necrosis.
DNA Electrophoresis
Snap-frozen myocardial samples were digested in lysis buffer
(urea, 4 mol/L; Tris HCl, 200 mmol/L; NaCl, 20 mmol/L; and
ethylenediamine tetraacetic acid [EDTA], 200 mmol/L [pH 7.4])
with proteinase K (3.3 mg/mL) purified with Miniprep columns
(Roche, Indianapolis, Ind), according to the manufacturer’s in-
structions. Equal masses of DNA were then digested with DNAse-
free RNAse (Roche), radiolabeled with phosphorous 32–labeled
deoxycytidine triphosphate (Amersham, Sunneyvale, Calif) and
Klenow (New England Biolabs, Beverly, Mass), and purified over
Sephadex G-50 (Amersham). Electrophoresis was performed in
1.8% agarose with EtBr at 5 V/cm for 2 hours. The gels were
photographed with UV light to confirm equal loading of DNA and
then dried and imaged with X-omat film (Eastman Kodak, Roch-
ester, NY). DNA was extracted from adult sheep heart as a
negative control and from peri-infarct lamb myocardium as a
positive control, as previously described.11
mRNA Microarray
Total cellular RNA was prepared from frozen myocardial samples
by using the RNEasy Protect Midi kit (Qiagen, Valencia, Calif)
and analyzed by using the Human Apoptosis-2 GEArray kit (Su-
perArray, Bethesda, Md), according to the manufacturers’ instruc-
tions. Transcript abundance was evaluated in comparison with
-actin and reduced glyceraldehyde-phosphate dehydrogenase by
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using a Storm 860 phosphor imager (Amersham Biosciences [Mo-
lecular Dynamics], Sunnyvale, Calif).
Caspase Activity Assay
A fluorimetric caspase activity assay was performed, as previously
described.12 Snap-frozen myocardial samples were homogenized
in cold detergent buffer (Tris-HCl, 10 mmol/L [pH 8.0]; Triton
X-100, 1%; sucrose, 0.32 mol/L; and EDTA, 5 mmol/L) with
proteinase inhibitors (phenylmethylsulfonyl fluoride, 1 mmol/L;
dithiothreitol, 2 mmol/L; leupeptin, 10 g/mL; and aprotinin, 10
g/mL) and cellular debris peleted at 13,000g for 10 minutes at
4°C. Supernatant protein concentration was standardized on the
basis of a chromogenic assay (Bio-Rad, Hercules, Calif). Samples
were diluted in assay buffer (sucrose, 10%; N-2-hydroxyeth-
ylpiperazine-N-2-ethanesulfonic acid, 100 mmol/L [pH 7.5]; NaCl,
100 mmol/L; and CHAPS, 0.1%) with proteinase inhibitors as
above. Tetrapeptide substrates of caspase 3 (Ac-DEVD-AFC),
caspase 8 (CBZ-IETD-AFC), and caspase 9 (Ac-LEHD-AFC; all
from Sigma, St Louis, Mo) were added (50 mol/L), and the
fluorescence before and after 1 hour of incubation at 37°C were
measured with a PerkinElmer LM50B fluorimeter (EG&G, Welle-
sley, Mass) and compared with a curve of known AFC concentra-
tions diluted in each sample.
Western Immunoblotting
Protein was purified from frozen left ventricular myocardial sam-
ples by means of homogenization in nondetergent lysis buffer
(Tris, 50 mmol/L; NaCl, 150 mmol/L; EDTA, 10 mmol/L [pH 7.5]
with leupeptin, 10 g/mL; 2-mercaptoethanol, 2 mmol/L; aproti-
nin, 10 g/mL; and phenylmethylsulfonyl fluoride, 1 mmol/L) and
centrifugation at 13,000g for 10 minutes at 4°C and then quantified
by means of chromogenic assay (Bio-Rad). Equal amounts of
protein were separated by means of sodium dodecylsulfate–poly-
acrylamide gel electrophoresis and transferred to nitrocellulose
membranes. Equal protein loading was confirmed by means of
Ponceau staining. Bcl-2 was detected with hamster monoclonal
anti-Bcl-2 IgG (BD Biosciences, Franklin Lakes, NJ). Bax was
detected with hamster monoclonal anti-Bax IgG2b (Santa Cruz
Biotechnology, Santa Cruz, Calif). Bcl-xL was detected with
mouse monoclonal or rabbit polyclonal antibody (both BD Bio-
sciences). Antigen-antibody complexes were labeled with appro-
priate horseradish peroxidase–conjugated secondary antibodies
and revealed with the SuperSignal enhanced chemiluminescence
kit (Pierce, Rockford, Ill). Chemiluminograms were digitized and
quantified by using the National Institutes of Health Image pro-
gram (rsbweb.nih.gov).
Data are expressed as means  SEM. Statistical comparisons
were performed by means of analysis of variance, followed by the
Student t test.
Results
Histology
The number of TUNEL-positive nuclei in left ventricular
sections after cardioplegia is depicted in Figure 1. There
were 3.42  0.76 positive nuclei per high-power fields
(representing approximately 0.82% of cells) compared with
0.72  0.17 per high-power fields in unoperated control
animals and 0.74  0.22 per high-power fields after bypass
only (P  .007 and P  .008, respectively). Representative
histologic findings with TUNEL, DAPI, and actin immuno-
fluorescence are shown in Figure 2. Nearly all TUNEL-
positive nuclei appeared in actin-containing cells, indicating
cardiomyocyte apoptosis. Adjacent sections stained with
hematoxylin and eosin showed no evidence of necrosis.
Radiolabeled DNA Electrophoresis
Figure 3 shows representative electrophoretic patterns
found in the postcardioplegic and control hearts. A ladder
pattern was observed in all postcardioplegia specimens. A
very faint ladder was found in some of the nonbypass
control animals. No ladder pattern was seen in specimens
from mature hearts.
mRNA Microarray
mRNA transcript levels for the 10 primary elements of the
microarray are summarized in figure 4. Significant increases
were seen in signal for Bad (5-fold increase, P  .002) and
Bcl-x (2-fold increase, P  .008). Differences in Bax,
Bcl-2, Bcl-w, and caspases 1, 3, 5, 6, 7, and 10 were not
significant.
Caspase Activity
Caspase 3-, 8-, and 9-like activities are illustrated in Figure
5. Caspase 3-like activity was 41  5 arbitrary units (AU)
after cardioplegia compared with 36  8 AU in unoperated
control animals and 39  9 AU after bypass alone. Caspase
8-like activity was 44  3 AU compared with 42  6 AU
in unoperated control animals and 34  7 AU after bypass
Figure 1. The number of TUNEL-positive nuclei per high-power
field in left ventricular myocardium after cardioplegia compared
with that seen in unoperated lambs and lambs subjected only to
cardiopulmonary bypass. Cryostat sections were TUNEL stained
and counterstained with DAPI. Fluorescent nuclei in 10 random
high-power fields per section were manually counted. TUNEL
positivity after cardioplegia was 5-fold greater than that seen in
unoperated control animals (P  .007) and bypass-only control
animals (P  .008).
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alone. Caspase 9-like activity was 47  8 AU compared
with 45  8 AU in unoperated control animals and 35  7
AU after bypass alone. None of these increases was statis-
tically significant.
Western Immunoblotting
No significant differences in protein levels of Bcl-2, Bax, or
Bcl-xL were detected between any groups. The ratio of Bcl-2
to Bax was also not significantly different in any group.
Discussion
We have observed increased apoptotic cell death and alter-
ations in certain proapoptotic and antiapoptotic signals in neo-
natal lambs 6 hours after cold hyperkalemic crystalloid car-
dioplegic arrest. Cardiomyocyte apoptosis as a consequence of
myocardial ischemia-reperfusion injury is a well-described
phenomenon.13 Only recently, however, has evidence of apo-
ptosis been sought after what is believed to be the protected
ischemia of brief, hypothermic, depolarized cardioplegic ar-
rest.10
The data that most significantly support the presence of
apoptosis after cardioplegic arrest in the neonatal lamb
come from TUNEL staining. This method has been very
widely applied in the study of myocardial apoptosis; how-
ever, its specificity has been questioned.14 To increase our
confidence in the specificity of TUNEL in our model, we
have combined TUNEL with immunofluorescent labeling of
cardiomyocytes through -actin. Although at earlier time
points after injury other investigators have identified more
prominent apoptosis among endothelial cells,15 the majority
of TUNEL-positive nuclei in our samples were seen in
actin-positive cells. More important, the specificity of
TUNEL in this study is supported by the finding of ladder
patterns in DNA from postcardioplegia hearts. Because
laddering is the result of internucleosomal cleavage of DNA
by endonucleases, it has previously been seen as a virtual
sine qua non of apoptosis. Although in experimentally pro-
duced necrosis false-positive laddering caused by endoge-
nous, Ca2- and Mg2-dependent endonucleases has been
reported,16 our technique included immediate freezing,
thawing in the presence of high EDTA concentrations to
inhibit endonucleases, and early proteinase K digestion of
nuclear proteins, after which DNA is susceptible only to
random length degradation.
The data from mRNA microarrays showed no increase in
most of the target transcripts; however, there was a highly
Figure 3. Representative autoradiogram of electrophoretically
separated, 32P-labeled deoxycytidine triphosphate end-labeled
DNA extracted from myocardial samples. Positive control and
postcardioplegia samples show prominent ladder pattern, indi-
cating in vivo internucleosomal DNA cleavage typical of the
terminal stages of apoptotic cell death. A very faint signal is seen
in samples from unoperated neonatal myocardium. Adult sheep
heart DNA shows no ladder.
Figure 2. Representative convergence of TUNEL staining (yellow-green), -actin immunofluorescence (red), and
DAPI nuclear counterstain (violet). Almost all TUNEL-positive nuclei within the substance of the myocardium were
associated with -actin, indicating predominance of cardiomyocytes.
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significant increase in signal for Bad, a proapoptotic effec-
tor, and for Bcl-x. The function of Bcl-x is to antagonize the
mitochondrial pathway of apoptosis induction. The mito-
chondrion releases cytochrome c in response to ischemic
injury and oxidative stress, forming a complex with cyto-
solic Apaf and procaspase 9 to yield active caspase 9 and
subsequently active caspase 3.17,18 Bcl-xL opposes this pro-
cess. Because TUNEL positivity was greater after cardio-
plegia than after cardiopulmonary bypass alone and because
the addition of cardioplegia imposes ischemia and oxidative
stress, the finding of early induction of Bcl-x transcription
corroborates our TUNEL findings.
The caspases are a family of highly specific proteases
that participate both in the activation of apoptosis and in its
execution. Caspase 3 is a central mediator: its activation is
associated with significant impairment of cardiac contrac-
tility and its inhibition restores hemodynamic performance
in certain models.19 Our finding of a lack of increase in
caspase 3 activity is in contrast with reports from rodent
models and from cultured cardiomyocytes20 and situations
involving more severe cardiac injuries.12 Human myo-
cardial apoptosis has been reported without caspase 3
activation.21-23
Caspases 8 and 9 are more upstream mediators in apo-
ptosis signaling. Caspase 8 is involved in transmitting cell-
surface apoptotic signals, such as from tumor necrosis factor
and Fas. Although cardiopulmonary bypass is known to
increase tumor necrosis factor and Fas levels,24-26 caspase 8
activity was not significantly different between groups.
Caspase 9 is activated by the mitochondrial pathway, as
described above. After cardioplegia, there was a more sug-
gestive but still nonsignificant trend (P  .16) to higher
caspase 9 activity than after bypass alone. The lack of
increased caspase activity despite TUNEL evidence of com-
pleted apoptosis might indicate that the fraction of cells
undergoing caspase activation was too small to detect above
intragroup variability. It is also possible that caspase activity
was opposed through apoptosis-regulatory mechanisms. Al-
ternatively, species variability in enzyme specificity for the
tetrapeptide substrates used might be responsible.
Figure 4. mRNA transcript abundance after cardioplegia (n  4) compared with that seen in unoperated neonatal
lambs (n  4) relative to the constitutively present -actin transcript. Increase in bad and bcl-x levels are
significant (P  .002 and P  .008, respectively). Other gene transcripts are not significantly altered.
Figure 5. Caspase 3–, 8 –, and 9 –like activity of total cellular protein from myocardium of unoperated control
animals, bypass-only control animals, and after cardioplegia per milligram of protein. Differences are not
significant.
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The lack of change in prevalence of Bcl-2 and Bax
protein levels neither supports nor refutes the occurrence of
apoptosis in this model. Bcl-family proteins are known to
exert many of their functions in the short term by altering
their subcellular localization or through homodimerization
and heterodimerization, rather than solely by means of de
novo expression.27-29 Unchanged bcl-xL protein abundance,
despite increased mRNA transcript abundance, might be
due to the acute nature of the stimulus.
Conclusion
We have observed increased apoptotic cell death and altered
expression of regulators and effectors of apoptosis in the
hearts of neonatal lambs subjected to a clinically relevant
period of cardioplegic arrest. Refinement of our model and
techniques will allow finer discrimination of the extent of
apoptosis and more specific determination of the instigating
stimuli. Further work will be required to evaluate the short-
and long-term consequences of postcardioplegia myocardial
apoptosis. Eventually, understanding the role of apoptosis in
the neonatal heart’s response to cardioplegia might provide
new insight into the study of myocardial protection tech-
niques and the phenomenon of myocardial stunning.
We acknowledge the expert technical assistance of Oliva Smith
and Kurt Bedell.
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Discussion
Dr Carl L. Backer (Chicago, Ill). I am filling in for Ross
Ungerleider, and right now I wish Ross were here.
Dr Hammel and associates from the University of Iowa Chil-
dren’s Hospital have performed a comprehensive evaluation of the
relationship between myocardial apoptosis, apoptosis-related me-
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